Clinical Trials Browser

Phase 1 × Axitinib × Other solid neoplasm × Clear all

NCT02164838 2018-01-29

VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors

Phase 1 Completed

Other solid neoplasm

Refractory or Recurrent Solid Tumors, Excluding CNS Tumors

NCT01469052 2012-03-26

First In Human, Phase 1 Study of AG013736 In Patients With Solid Tumors

Phase 1 Completed

36 enrolled 16 charts

Other solid neoplasm

Advanced Solid Tumors

NCT00949624 2012-01-19

CP-868,596 And CP-868,596 Plus AG-013736 In Combination With Docetaxel In Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumors